Related references
Note: Only part of the references are listed.Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy
Arjun Sahgal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation core
Ashley E. Rosko et al.
JOURNAL OF GERIATRIC ONCOLOGY (2021)
Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age
Dora Niedersuess-Beke et al.
CANCERS (2021)
Prognostic value of two geriatric screening tools in a cohort of older Check tor patients with early stage Non-Small Cell Lung Cancer treated with hypofractionated stereotactic radiotherapy
Francesco Cuccia et al.
JOURNAL OF GERIATRIC ONCOLOGY (2020)
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes
Rosario Mazzola et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Evolving Role of Stereotactic Body Radiation Therapy in the Management of Spine Metastases Defining Dose and Dose Constraints
Fabio Y. Moraes et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2020)
Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer
Emile Gogineni et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Moderate hypofractionated helical tomotherapy for prostate cancer in a cohort of older patients: a mono-institutional report of toxicity and clinical outcomes
F. Cuccia et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2020)
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review
Liliana Belgioia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities
Alba Fiorentino et al.
RADIOLOGIA MEDICA (2019)
Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients: Amono-institutional experience on 110 brain metastases
Fabiana Gregucci et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
Oligometastatic cancer in elderly patients: the blitzkrieg radiotherapy approach: SBRT in oligometastatic elderly patients
Andrea Lancia et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2019)
Practice Patterns and Outcomes in Elderly Stage I Non-Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis
Shraddha M. Dalwadi et al.
CLINICAL LUNG CANCER (2018)
30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease
M. F. Osti et al.
LUNG CANCER (2018)
Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer
Daniel W. Yokom et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Significance of stereotactic body radiotherapy in older patients with early stage non-small cell lung cancer
Toshiya Maebayashi et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review
Karis Kin-Fong Cheng et al.
BMJ OPEN (2018)
Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy
Erqi L. Pollom et al.
SEMINARS IN RADIATION ONCOLOGY (2017)
Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80 years old): Extremely safe and effective
Paul Kreinbrink et al.
JOURNAL OF GERIATRIC ONCOLOGY (2017)
UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy
G.G. Hanna et al.
CLINICAL ONCOLOGY (2017)
Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer
Karlijn J. G. Schulkes et al.
CLINICAL LUNG CANCER (2017)
Never too old: A single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer
Gregory M. M. Videtic et al.
PRACTICAL RADIATION ONCOLOGY (2017)
The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly
Marta Scorsetti et al.
BRITISH JOURNAL OF RADIOLOGY (2015)
Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: The ELCAPA-02 study
Evelyne Liuu et al.
JOURNAL OF GERIATRIC ONCOLOGY (2014)
Cancer and Age: General Considerations
Sarah Hoffe et al.
CLINICS IN GERIATRIC MEDICINE (2012)
Share Paper
